- Home
- ALVO vs WNS Comparison
ALVO vs WNS Comparison
Compare ALVO & WNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- WNS
- Stock Information
- Founded
- ALVO 2013
- WNS 1996
- Country
- ALVO Luxembourg
- WNS India
- Employees
- ALVO N/A
- WNS N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- WNS Business Services
- Sector
- ALVO Health Care
- WNS Consumer Discretionary
- Exchange
- ALVO Nasdaq
- WNS Nasdaq
- Market Cap
- ALVO 3.4B
- WNS 2.8B
- IPO Year
- ALVO N/A
- WNS N/A
- Fundamental
- Price
- ALVO $8.29
- WNS $66.58
- Analyst Decision
- ALVO Buy
- WNS Buy
- Analyst Count
- ALVO 1
- WNS 9
- Target Price
- ALVO $18.00
- WNS $62.89
- AVG Volume (30 Days)
- ALVO 162.8K
- WNS 821.4K
- Earning Date
- ALVO 05-20-2025
- WNS 04-24-2025
- Dividend Yield
- ALVO N/A
- WNS N/A
- EPS Growth
- ALVO N/A
- WNS N/A
- EPS
- ALVO N/A
- WNS 2.70
- Revenue
- ALVO $491,978,000.00
- WNS $1,315,456,000.00
- Revenue This Year
- ALVO $33.92
- WNS N/A
- Revenue Next Year
- ALVO $45.74
- WNS $7.90
- P/E Ratio
- ALVO N/A
- WNS $24.68
- Revenue Growth
- ALVO 426.85
- WNS 1.07
- 52 Week Low
- ALVO $7.35
- WNS $39.85
- 52 Week High
- ALVO $14.76
- WNS $72.11
- Technical
- Relative Strength Index (RSI)
- ALVO 32.92
- WNS 58.10
- Support Level
- ALVO $8.25
- WNS $58.56
- Resistance Level
- ALVO $8.98
- WNS $68.18
- Average True Range (ATR)
- ALVO 0.55
- WNS 4.17
- MACD
- ALVO -0.01
- WNS 0.17
- Stochastic Oscillator
- ALVO 36.86
- WNS 59.19
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a Global provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), and South Africa.